---
schema_version: "secwatch.filing_event.v1"
accession: "0001522767-22-000012"
form_type: "8-K"
ticker: "MRMD"
cik: "0001522767"
company_name: "MARIMED INC."
filed_at: "2022-11-07T23:59:59+00:00"
generated_at: "2026-06-22T05:20:21.507135+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# MariMed Q3 revenue $33.9M (+2% YoY); adjusted EBITDA falls 32% to $8.6M

## Summary
- Revenue $33.9M vs $33.2M in Q3 2021, a 2% YoY increase.
- GAAP net income $2.7M, up from $2.1M YoY.
- Non-GAAP adjusted EBITDA $8.6M, down from $12.6M YoY; margin 25% vs 38%.
- Gross margin declined to 48% from 55% YoY.
- CEO cites industry headwinds but highlights strength in retail and wholesale.

## SEC filing metadata
- accession: 0001522767-22-000012
- form_type: 8-K
- ticker: MRMD
- cik: 0001522767
- company_name: MARIMED INC.
- filed_at: 2022-11-07T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1522767/000152276722000012/0001522767-22-000012-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1522767/000152276722000012/mrmd-20221107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001522767-22-000012
- JSON: https://secwatch.observer/filing/0001522767-22-000012.json
- Plain text: https://secwatch.observer/filing/0001522767-22-000012.txt

## Key facts
- Earnings Releases
  MARIMED INC. reported third quarter ended September 30, 2022 results: revenue $33.9, net income $2.7.
  - Period: third quarter ended September 30, 2022
  - Revenue: $33.9
  - Net income: $2.7
  - Result: reported results
  source text: financial highlights for the three months ended September 30, 2022 and 2021 (in millions, except percentage amounts): Three months ended September 30, 2022 2021 Revenue $ 33.9 $ 33.2 Gross margin 48 % 55 % GAAP Net income $ 2.7 $ 2.1 Non-GAAP Adjusted EBITDA $ 8.6 $ 12.6 Non-GAAP Adjusted EBITDA margin 25 % 38 % 1 See the reconciliations of
  evidence_url: https://www.sec.gov/Archives/edgar/data/1522767/000152276722000012/0001522767-22-000012-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.